Skip to main content
. 2022 Mar 14;13(1):530–541. doi: 10.1080/21505594.2022.2040190

Table 5.

The specificity of established competitive inhibition ELISA

Serum Inhibition rate
(%, mean±SD)
Serum Inhibition rate
(%, mean±SD)
H1 7.02 ± 1.29 H7-Re2 48.56 ± 3.98
H3 9.72 ± 3.15 H7-GD4 (Immune) 52.24 ± 1.83
H4 6.58 ± 3.71 H7-JD/17 (Immune) 54.87 ± 2.81
H5 (Re-8) 4.57 ± 2.87 H7-GD4 (Infected) 56.79 ± 3.76
H5 (Re-11) 11.45 ± 3.59 H7-JD/17 (Infected) 55.33 ± 3.06
H5 (Re-12) 6.55 ± 1.03 H7-rGD4HALo-mH3-TX 4.89 ± 1.43
H6 10.61 ± .81    
H9 9.62 ± 1.18    
H10 8.28 ± 1.59